Speaker

Eric Falcand

VICE PRESIDENT GLOBAL HEAD OF BUSINESS DEVELOPMENT, SERVIER
Suresnes, France
Vice President Global Head of Business Development, Eric Falcand has over 30 years’ experience in the pharmaceutical industry in Business Development, General Management & Alliance Management, and commercialization.
From international commercial operations at Virbac and Sanofi, he joined Servier in 1997 as a General Manager in Russia, became CEO of the UK branch and took the responsibility of the US partnerships and licenses in Servier’s Paris headquarters before being appointed as the Vice President Global Head of Business Development in 2015.
In 2018, Eric has successfully negotiated the acquisition of the Shire Oncology business worth US$ 2.4 billion, establishing Servier commercial presence in the USA, and more recently in 2020, the acquisition of the Danish company Symphogen reinforcing Servier’s expertise and portfolio in monoclonal Ab and of the Agios oncology portfolio worth US$ 2.0 reinforcing Servier commercial and R&D presence in the USA, deal closed on March 31st, 2021.
Eric holds a Doctorate in Veterinary Medicine, a master’s in industrial pharmacy and a MBA from EM Lyon.
Speaking In
2:30 PM - 2:45 PM
Tuesday, June 6
Servier is an independent pharmaceutical company committed to therapeutic progress to serve patient…
Session Room 104B
4:15 PM - 5:15 PM
Wednesday, June 7
What do biotech companies need to consider as they develop their global growth strategy? Companies…